Induction of synthesis of a large heparan sulfate proteoglycan, perlecan, by thrombin in cultured human coronary smooth muscle cells

Biochimica et Biophysica Acta - General Subjects

Volumn 1722, Issue 1, 2005, Pages 92-102

  Yamamoto, Chika ^a   Wakata, Takako ^a   Fujiwara, Yasuyuki ^a   Kaji, Toshiyuki ^a  

^a HOKURIKU UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; Extracellular matrix; Perlecan; Proteoglycan; Thrombin; Vascular

Indexed keywords

AMINO ACID; BIGLYCAN; CHONDROITIN ABC LYASE; CORE PROTEIN; DECORIN; GLYCOSAMINOGLYCAN; MESSENGER RNA; PAPAIN; PERLECAN; PROTEOGLYCAN; PROTEOHEPARAN SULFATE; SEPHAROSE; SULFATE; SULFUR 35; SYNDECAN 1; THROMBIN; VERSICAN;

ARTICLE; ATHEROSCLEROSIS; CELL CULTURE; CELL DENSITY; CHROMATOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY; DIGESTION; HUMAN; HUMAN CELL; ISOTOPE LABELING; METABOLISM; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; STEADY STATE; WESTERN BLOTTING;

EID: 13544251474     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2004.11.017     Document Type: Article

References (53)

1. T.N. Wight Cell biology of arterial proteoglycans Atherosclerosis 9 1989 1 20
2. E.A. Clark, and J.S. Brugge Integrins and signal transduction pathways: the road taken Science 268 1995 233 239
3. R.K. Assoian, and E.E. Marcantonio The extracellular matrix as a cell cycle control element in atherosclerosis and restenosis J. Clin. Invest. 98 1996 2436 2439
4. U. Hedin, J. Roy, P.K. Tran, K. Lundmark, and A. Rahman Control of smooth muscle cell proliferation: the role of the basement membrane Thromb. Haemost. 82 S1 1999 23 26
5. E. Ruoslahti Structure and biology of proteoglycans Annu. Rev. Cell Biol. 4 1988 229 255
6. T. Saku, and H. Furthmayr Characterization of the major heparan sulfate proteoglycan secreted by bovine aortic endothelial cells in culture: homology to the large molecular weight molecule of basement membrane J. Biol. Chem. 264 1988 3514 3523
7. H.T. Järveläinen, M.G. Kinsella, T.N. Wight, and L.J. Sandell Differential expression of small chondroitin/dermatan sulfate proteoglycans, PG-I/biglycan and PG-II/decorin, by vascular smooth muscle and endothelial cells in culture J. Biol. Chem. 266 1991 23274 23281
8. L.Y. Yao, C. Moody, E. Schönherr, T.N. Wight, and L.J. Sandell Identification of the proteoglycan versican in aorta and smooth muscle cells by DNA sequence analysis, in situ hybridization and immunohistochemistry Matrix Biol. 14 1994 213 225
9. E. Schönherr, H.T. Järveläinen, M.G. Kinsella, L.J. Sandell, and T.N. Wight Platelet-derived growth factor and transforming growth factor-β1 differentially affect the synthesis of biglycan and decorin by monkey arterial smooth muscle cells Atheroscler. Thromb. 13 1993 1026 1036
10. 1 in cultured bovine aortic endothelial cells J. Biol. Chem. 275 2000 1463 1470
11. E. Schönherr, H.T. Järveläinen, L.J. Sandell, and T.N. Wight Effects of platelet-derived growth factor and transforming growth factor-β1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells J. Biol. Chem. 266 1991 17640 17647
12. J.M. Herbert, E. Dupuy, M.C. Laplace, J.M. Zini, R. Bar Shavit, and G. Tobelem Thrombin induces endothelial cell growth via both a proteolytic and a non-proteolytic pathway Biochem. J. 303 1994 227 231
13. B.B. Weksler, C.W. Ley, and E.A. Jaffe Stimulation of endothelial cell prostaglandin production by thrombin, trypsin and the ionophore A23187 J. Clin. Invest. 62 1978 923 930
14. E.G. Levin, and D.J. Loskutoff Cultured bovine aortic endothelial cells produce both urokinase and tissue-type plasminogen activators J. Cell Biol. 94 1982 631 636
15. T.D. Gelehrter, and R. Sznycer-Laszuk Thrombin induction of plasminogen activator inhibitor in cultured human endothelial cells J. Clin. Invest. 77 1986 165 169
16. C.A. McNamara, U. Sarembock, L.W. Gimple, J.W. Fenton II, S.R. Coughlin, and G.K. Owens Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor J. Clin. Invest. 91 1993 94 98
17. N. Fujii, T. Kaji, T. Akai, and F. Koizumi Thrombin reduces large heparan sulfate proteoglycan molecules in cultured vascular endothelial cell layers through inhibition of core protein synthesis Thromb. Res. 88 1997 299 307
18. Å. Wasteson, K. Uthne, and B. Westermark A novel assay for the biosynthesis of sulphated polysaccharide and its application to studies on the effects of somatomedin on cultured cells Biochem. J. 136 1973 1069 1074
19. Å. Wasteson A method for the determination of the molecular weight and molecular-weight distribution of chondroitin sulfate J. Chromatogr. 59 1971 87 97
20. U.K. Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 1970 680 685
21. H. Hatakeyama, I. Miyamori, T. Fujita, Y. Takeda, R. Takeda, and H. Yamamoto Vascular aldosterone. Biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells J. Biol. Chem. 269 1994 24316 24320
22. A.H. Plaas, L.A. West, and R.J. Midura Keratan sulfate disaccharide composition determined by FACE analysis of keratanase II and endo-beta-galactosidase digestion products Glycobiology 11 2001 779 790
23. D. Aviezer, D. Hecht, M. Safran, M. Eisinger, G. David, and A. Yayon Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis and angiogenesis Cell 79 1994 1005 1013
24. Y. Yamaguchi, D.M. Mann, and E. Ruoslahti Negative regulation of transforming growth factor-beta by the proteoglycan decorin Nature 346 1990 281 284
25. G. Mertens, J. Cassiman, H.V. Berghe, J. Vermylen, and G. David Cell surface heparan sulfate proteoglycans from human vascular endothelial cells. Core protein characterization and antithrombin III binding properties J. Biol. Chem. 267 1992 20435 20443
26. K.D. O'Brien, K.L. Olin, C.E. Alpers, W. Chui, M. Ferguson, K. Hudkins, T.N. Wight, and A. Chait Comparison of apolipoprotein and proteoglycan deposits in human coronary atherosclerotic plaques: colocalization of biglycan with apolipoproteins Circulation 98 1998 519 527
27. U. Hedin, B.A. Bottger, E. Forsberg, S. Johansson, and J. Thyberg Diverse effects of fibronectin and laminin on phenotype properties of cultured arterial smooth muscle cells J. Cell Biol. 107 1988 307 319
28. S.P. Evanko, E.W. Raines, R. Ross, L.I. Gold, and T.N. Wight Proteoglycan distribution in lesions of atherosclerosis depends on lesion severity, structural characteristics, and the proximity of platelet-derived growth factor and transforming growth factor-beta Am. J. Pathol. 152 1998 533 546
29. J.K. Belknap, M.C. Weiser-Evans, S.S. Grieshaber, R.A. Majack, and K.R. Stenmark Relationship between perlecan and tropoelastin gene expression and cell replication in the developing rat pulmonary vasculature Am. J. Respir. Cell Mol. Biol. 20 1999 24 34
30. M.C.M. Weiser, S.S. Grieshaber, J.K. Belknap, M.G. Kinsella, and R.A. Majack Developmental regulation of perlecan gene expression in aortic smooth muscle cells Matrix Biol. 15 1996 331 340
31. R.T. Lee, C. Yamamoto, Y. Feng, S. Potter-Perigo, W.H. Briggs, K.T. Landschulz, T.G. Turi, J.F. Thompson, P. Libby, and T.N. Wight Mechanical strain induces specific changes in the synthesis and organization of proteoglycans by vascular smooth muscle cells J. Biol. Chem. 276 2001 13847 13851
32. R. Shimizu-Horita, H. Sasamura, M. Mifune, H. Nakaya, M. Kuroda, M. Hayashi, and T. Saruta Regulation of vascular proteoglycan synthesis by angiotensin II type 1 and type 2 receptors J. Am. Soc. Nephrol. 12 2001 2609 2615
33. R.A. Majack Beta-type transforming growth factor specifies organizational behavior in vascular smooth muscle cell cultures J. Cell Biol. 105 1987 465 471
34. S. Hiraga, T. Kaji, Y. Ueda, F. Zisaki, K. Iwata, F. Koizumi, Y. Okada, S. Katsuda, and I. Nakanishi Modulation of collagen synthesis by tumor necrosis factor alpha in cultured vascular smooth muscle cells Life Sci. 66 2000 235 244
35. T. Kaji, S. Hiraga, C. Yamamoto, Y. Fujiwara, Y. Ueda, F. Zisaki, K. Iwata, Y. Okada, and S. Katsuda Effects of tumor necrosis factor-α on the synthesis of DNA, the secretion of matrix metalloproteinases/tissue inhibitors of metalloproteinases, and the activity of invasive migration in cultured vascular smooth muscle cells J. Health Sci. 48 2002 354 358
36. T. Kaji, S. Hiraga, C. Yamamoto, Y. Fujiwara, Y. Ueda, F. Zisaki, K. Iwata, S. Katsuda, and I. Nakanishi Vascular smooth muscle cells in culture express tumor necrosis factor-α that suppresses collagen synthesis depending on cell density J. Health Sci. 49 2003 115 122
37. Z. Tao, F.W. Smart, J.E. Flgueroa, D.L. Glancy, and P. Vijayagopal Elevated expression of proteoglycans in proliferating vascular smooth muscle cells Atherosclerosis 135 1997 171 179
38. M.G. Kinsella, P.-K. Tran, M.C.M. Weiser-Evans, M. Reidy, R.A. Majack, and T.N. Wight Changes in perlecan expression during vascular injury. Role in the inhibition of smooth muscle cell proliferation in the late lesion Arterioscler. Thromb. Vasc. Biol. 23 2003 608 614
39. M. Romaris, A. Heredia, A. Molist, and A. Bassols Differential effect of transforming growth factor beta on proteoglycan synthesis in human embryonic lung fibroblasts Biochim. Biophys. Acta 1093 1991 229 233
40. V.M. Kähäri, H. Larjava, and J. Uitto Differential regulation of extracellular matrix proteoglycan (PG) gene expression. Transforming growth factor-beta 1 up-regulates biglycan (PGI), and versican (large fibroblast PG) but down-regulates decorin (PGII) mRNA levels in human fibroblasts in culture J. Biol. Chem. 266 1991 10608 10615
41. R. Heimer, R.I. Bashey, J. Kyle, and S.A. Jimenez TGF-beta modulates the synthesis of proteoglycans by myocardial fibroblasts in culture J. Mol. Cell. Cardiol. 27 1995 2191 2198
42. J.C. Goldsmith, C.T. Jafvert, P. Lollar, W.G. Owen, and J.C. Hoak Prostacyclin release from cultured and ex vivo bovine vascular endothelium. Studies with thrombin, arachidonic acid, and ionophore A23187 Lab. Invest. 45 1981 191 197
43. K. Lundmark, P.K. Tran, M.G. Kinsella, A.W. Clows, T.N. Wight, and U. Hedin Perlecan inhibits smooth muscle cell adhesion to fibronectin: role of heparan sulfate J. Cell. Physiol. 188 2001 67 74
44. J.H. Campbell, R.E. Rennick, S.G. Kalevitch, and G.R. Campbell Heparan sulfate-degrading enzymes induce modulation of smooth muscle cell phenotype Exp. Cell Res. 200 1992 156 167
45. M.G. Kinsella, C. Irvin, M.A. Reidy, and T.N. Wight Removal of heparan sulfate by heparinase treatment inhibits FGF-2-dependent smooth muscle cell proliferation in injured rat carotid arteries Atherosclerosis 175 2004 51 57
46. T.K. Vu, D.T. Hung, V.I. Wheaton, and S.R. Coughlin Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation Cell 64 1991 1057 1068
47. J.M. Herbert, I. Lamarche, and F. Dol Induction of vascular smooth muscle cell growth by selective activation of the thrombin receptor. Effect of heparin FEBS Lett. 301 1992 155 158
48. K. Dabbagh, G.L. Laurent, R.J. McAnulty, and R.C. Chambers Thrombin stimulates smooth muscle cell procollagen synthesis and mRNA levels via a PAR-1 mediated mechanism Thromb. Haemost. 79 1998 405 409
49. N.A. Nelken, S.J. Soifer, J. O'Keefe, T.K. Vu, I.F. Charo, and S.R. Coughlin Thrombin receptor expression in normal and atherosclerotic human arteries J. Clin. Invest. 90 1992 1614 1621
50. R. Dechend, X. Mo, W. Schulz, M. Gross, M. Praus, R. Dietz, and D.C. Gulba Thrombin receptor and urokinase-type plasminogen activator are colocalized in vascular smooth muscle cells derived from human carotid atherosclerotic plaques Fibrinolysis 10 1996 41 45
51. E. Bretschneider, R. Spanbroek, K. Lotzer, A.J. Habenicht, and K. Schrör Evidence for functionally active protease-activated receptor-3 (PAR-3) in human vascular smooth muscle cells Thromb. Haemost. 90 2003 704 709
52. E. Bretschneider, R. Kaufman, M. Braun, G. Nowak, E. Glusa, and K. Schrör Evidence for functionally active protease-activated receptor-4 (PAR-4) in human vascular smooth muscle cells Br. J. Pharmacol. 132 2001 1441 1446
53. R.M. Scaborough, M.A. Naughton, W. Teng, D.T. Hung, J. Rose, T.K. Vu, V.I. Wheaton, C.W. Turck, and S.R. Coughlin Tethered ligand agonist peptides. Structural requirements for thrombin receptor activation reveal mechanism of proteolytic unmasking of agonist function J. Biol. Chem. 267 1992 13146 13149